Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if kidney function can be improved during transplants by
giving the drug Thymoglobulin with delayed cyclosporine treatment instead of initial
cyclosporine treatment.
There have been improvements for patients receiving kidney transplants, yet acute rejection
is still a problem. This can lead to kidney failure over time. Patients whose graft fails to
function properly in the first week after transplant do not do as well after 5 years as
compared to patients without early problems. This study will see if Thymoglobulin, a drug
that suppresses the immune system, will improve early graft function.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)